James Joaquin is a former repeat tech founder and CEO of seven companies who co-created the term "world positive" venture capital, emphasizing investments in high-growth mainstream businesses whose core products inherently create positive environmental or social outcomes rather than traditional impact investing with concessionary returns. He pioneered the "World Positive / ESG Term Sheet" concept that bakes mission and stakeholder considerations into company governance from day one, and approaches venture investing as "time machine building" by backing founders whose companies feel like they're importing a better future into the present.

• Focuses heavily on the concept of food as medicine and functional nutrition trends. He frequently highlights specific dietary shifts, such as the rise of rare sugars like allulose as a sweetener alternative, and the transition away from seed oils toward healthier fats like avocado and olive oil.
• Interest in the intersection of artificial intelligence and biology, which he refers to as Generative Science. He frames AI not just as a tech tool but as a fundamental shift in how we create, noting that writing was the first skill AI demonstrated real competency in, comparable to the protagonist's job in the film Her.
• Enthusiasm for novel mental health interventions and the psychedelic renaissance. He has predicted the mainstreaming of metabolic psychiatry, such as using medical ketosis for brain health, and follows regulatory progress on MDMA and psilocybin for treating conditions like PTSD.
• Prioritizes sustainability and climate solutions under a World Positive thesis. This includes interest in reducing virgin plastics in packaging by switching to aluminum and agricultural innovations like algae-based feed supplements to lower methane emissions from livestock.
• Attention to longevity and direct-to-consumer healthcare. He tracks the growing market for proactive wellness products, from peptides and hormone replacement therapies to personalized organ regeneration, such as research into replacement human hearts.
• Support for workforce innovation within the healthcare sector. He champions platforms that address critical labor shortages, specifically citing tools that help nurses manage their careers and remain in the field until retirement.